AnalystsPatrick R. TrucchioPatrick R. Trucchio's Stock Forecasts
AnalystsPatrick R. Trucchio
Sectors:
Industries:
Analyst Ranking
Top 14%
#716 out of 5177 analysts
Average Return
+20.63%
Win Rate
61%27 out of 44
Risk vs Reward
Poor
Good
Patrick R. Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +399.12% | $3.41 | $17.02 | 2025-08-18 - 2026-01-15 | Buy |
Invivyd IncIVVD | +180.14% | $0.87 | $2.44 | 2025-08-27 - 2026-01-15 | Buy |
Arrowhead Pharmaceuticals IncARWR | +157.98% | $25.68 | $66.25 | 2025-09-02 - 2026-01-15 | Buy |
Arrowhead Pharmaceuticals IncARWR | +79.34% | $36.94 | $66.25 | 2025-10-08 - 2026-01-15 | Buy |
Alto Neuroscience IncANRO | +54.73% | $11.00 | $17.02 | 2025-10-24 - 2026-01-15 | Buy |
Patrick R. Trucchio Analyst Color
Get additional color on Patrick R. Trucchio's coverage of popular stocks
Patrick R. Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bright Minds Biosciences IncDRUG | 3 | Buy | $115.00 | N/A | Reiterates | 18 days ago |
Vir Biotechnology IncVIR | 2 | Buy | $15.00 | +141.94% | Reiterates | 18 days ago |
Assembly Biosciences IncASMB | 2 | Buy | $50.00 | +67.17% | Reiterates | a month ago |
Nrx Pharmaceuticals IncNRXP | 4 | Buy | $40.00 | +1,760.47% | Reiterates | a month ago |
Marker Therapeutics IncMRKR | 1 | Buy | $10.00 | +468.18% | Initiates Coverage On | a month ago |
Pharvaris NvPHVS | 3 | Buy | $60.00 | +133.92% | Reiterates | a month ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Buy | $85.00 | +28.30% | Maintains | a month ago |
Harmony Biosciences Holdings IncHRMY | 2 | Buy | $55.00 | +51.06% | Reiterates | 2 months ago |
Oncolytics Biotech IncONCY | 1 | Buy | $10.00 | +927.75% | Maintains | 2 months ago |
Cybin IncHELP | 1 | Buy | $55.00 | +600.64% | Maintains | 2 months ago |
Voyager Therapeutics IncVYGR | 2 | Buy | $25.00 | +554.45% | Maintains | 2 months ago |
Gh Research PLCGHRS | 1 | Buy | $35.00 | +106.37% | Maintains | 2 months ago |
Uniqure NvQURE | 5 | Buy | $70.00 | +218.47% | Maintains | 2 months ago |
Invivyd IncIVVD | 3 | Buy | $10.00 | +309.84% | Maintains | 2 months ago |
Alto Neuroscience IncANRO | 2 | Buy | $50.00 | +193.77% | Maintains | 3 months ago |
Immunocore Holdings PLCIMCR | 1 | Buy | $100.00 | +205.34% | Reiterates | 3 months ago |
Altimmune IncALT | 2 | Buy | $12.00 | +183.02% | Reiterates | 3 months ago |
Beam Therapeutics IncBEAM | 2 | Buy | $80.00 | +149.61% | Reiterates | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Buy | $570.00 | +58.66% | Reiterates | 3 months ago |
Atai Beckley NvATAI | 1 | Buy | $15.00 | +304.31% | Reiterates | 4 months ago |
Silence Therapeutics PLCSLN | 1 | Buy | $75.00 | +1,248.92% | Reiterates | 4 months ago |
Aligos Therapeutics IncALGS | 2 | Buy | $50.00 | +505.33% | Reiterates | 4 months ago |
Sangamo Therapeutics IncSGMO | 1 | Buy | $10.00 | +2,225.58% | Reiterates | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.